Dr. Matthew B. Harms
Overview
Matthew Harms, MD is an Associate Professor of Neurology. Dr. Harms received his A.B. in Biology summa cum laude from Harvard University in 1997, and his medical doctorate from the University of California San Francisco in 2003. He remained at San Francisco for neurology residency and served as Chief Resident in his final year. Dr. Harms completed neuromuscular medicine and clinical neurophysiology fellowships under the mentorship of Dr. Alan Pestronk at Washington University in St. Louis. His clinical training in neuromuscular diseases led him into the laboratory of Dr. Robert Baloh, where his post-doctoral research identified the genes responsible for two orphan human diseases- dominant spinal muscular atrophy with lower extremity predominance and limb-girdle muscular dystrophy type 1D.Dr. Harms joined the neuromuscular medicine faculty at Washington University in 2009 with board certifications in neurology, clinical neurophysiology, and neuromuscular medicine. In 2011, Dr. Harms assumed leadership of the Washington University Neuromuscular Genetics Project and established his research laboratory to continue harnessing emerging genetic technologies to understand the causes of inherited neuromuscular diseases. The lab focuses on diseases of the motor neuron, including amyotrophic lateral sclerosis, spinal muscular atrophy, and the hereditary motor neuropathies, and where his efforts have helped identify more than 5 novel disease genes. Here at Columbia, he will continue these efforts, directing an international multi-site effort using whole genome and transcriptome sequencing to bring precision medicine to amyotrophic lateral sclerosis. His laboratory efforts will occur in both the Motor Neuron Center and the Institute for Genomic Medicine.
Dr. Harms is highly rated in 11 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3.
His clinical research consists of co-authoring 103 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
710 West 168th Street, New York, NY 10032
Additional Areas of Focus
Dr. Harms has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Presbyterian Hospital
Douglas Sproule is a Neuromusculoskeletal Medicine provider in New York, New York. Dr. Sproule is highly rated in 4 conditions, according to our data. His top areas of expertise are Spinal Muscular Atrophy Type 1, Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, and Spinal Muscular Atrophy Type 2.
CUIMC/Neurological Institute Of New York
Dr. Neil Shneider is a physician-scientist with expertise in neuromuscular development and disease. He is a graduate of Harvard College and of the MD-PhD program of the Columbia University College of Physicians and Surgeons, and he was Chief Resident of the Harvard Longwood Neurology Training Program. Dr. Shneider completed his graduate work in the laboratory of Dr. Richard Axel and his postdoctoral fellowship in the laboratory of Dr. Thomas Jessell. After several years in the Intramural Program of the National Institute of Neurological Disorders and Stroke, Dr. Shneider returned to Columbia University as Assistant Professor of Neurology in the Neuromuscular Division. He is a member of the Center for Motor Neuron Biology and Disease and of the H. Houston Merritt Clinical Research Center. Dr. Shneider has clinical expertise in the diagnosis and care of patients with ALS and related motor neuron diseases. Dr. Shneider is highly rated in 6 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.
Werner K Doyle M.D. PC
Orrin Devinsky is a Neurologist in New York, New York. Dr. Devinsky is highly rated in 31 conditions, according to our data. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.
Frequently Asked Questions about Dr. Matthew B. Harms
How do I make an appointment with Dr. Matthew B. Harms?
You can book an appointment with Dr. Matthew B. Harms by calling their office at 646-426-3876. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew B. Harms a top-rated expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew B. Harms is classified as an Elite expert for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew B. Harms specialize in?
While Dr. Matthew B. Harms is a Neuromusculoskeletal Medicine, they have specific expertise in Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Spinal Muscular Atrophy (SMA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neuromusculoskeletal Medicine.
Does Dr. Matthew B. Harms participate in research or clinical trials?
Yes. Dr. Matthew B. Harms has published 102 articles and abstracts on conditions like Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). You can view a list of Dr. Matthew B. Harms's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Matthew B. Harms accept my insurance?
Dr. Matthew B. Harms accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 646-426-3876 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Primary Lateral SclerosisDr. Harms isElite. Learn about Primary Lateral Sclerosis.
- Distinguished
- Limb-Girdle Muscular DystrophyDr. Harms isDistinguished. Learn about Limb-Girdle Muscular Dystrophy.
- Spinal and Bulbar Muscular AtrophyDr. Harms isDistinguished. Learn about Spinal and Bulbar Muscular Atrophy.
- Spinal Muscular Atrophy (SMA)Dr. Harms isDistinguished. Learn about Spinal Muscular Atrophy (SMA).
- Spinal Muscular Atrophy Type 3Dr. Harms isDistinguished. Learn about Spinal Muscular Atrophy Type 3.
- Advanced
- Charcot-Marie-Tooth DiseaseDr. Harms isAdvanced. Learn about Charcot-Marie-Tooth Disease.
- DysarthriaDr. Harms isAdvanced. Learn about Dysarthria.
- DysferlinopathyDr. Harms isAdvanced. Learn about Dysferlinopathy.
- Miyoshi MyopathyDr. Harms isAdvanced. Learn about Miyoshi Myopathy.
- Riboflavin Transporter Deficiency Neuronopathy
- Experienced
- Centronuclear MyopathyDr. Harms isExperienced. Learn about Centronuclear Myopathy.
- Chiari MalformationDr. Harms isExperienced. Learn about Chiari Malformation.
- Chiari Malformation Type 2Dr. Harms isExperienced. Learn about Chiari Malformation Type 2.
- Congenital Fiber-Type DisproportionDr. Harms isExperienced. Learn about Congenital Fiber-Type Disproportion.
- Cytoplasmic Body MyopathyDr. Harms isExperienced. Learn about Cytoplasmic Body Myopathy.
- Delta-SarcoglycanopathyDr. Harms isExperienced. Learn about Delta-Sarcoglycanopathy.